Hayward, CA, United States of America

Srinivas Paladugu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.6

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):

Title: Srinivas Paladugu: Innovator in Pharmaceutical Compounds

Introduction

Srinivas Paladugu, a prominent inventor based in Hayward, California, has made significant contributions to the field of pharmaceuticals with his innovative research and patents. With two patents to his name, Srinivas is recognized for his work in developing compounds that have the potential to treat various diseases.

Latest Patents

Srinivas Paladugu's latest inventions include notable patents focused on thiazole compounds. The first patent encompasses "thiazole compounds and methods of use thereof," which describes compounds characterized by a specific structural formula and methods for utilizing these compounds in treating diseases, disorders, or conditions. The second patent, "compounds as inhibitors of AXL," discusses compounds that inhibit AXL, outlining synthesis methods and applications for treating a diverse array of conditions, including cancer.

Career Highlights

Srinivas currently works at Arcus Biosciences, Inc., where he continues to push the boundaries of pharmaceutical innovation. His efforts in researching and developing novel compounds highlight his commitment to advancing medicinal treatments that can significantly improve patient outcomes.

Collaborations

Throughout his career, Srinivas has collaborated with talented professionals in the field, including coworkers Joel Worley Beatty and Corinne Nicole Foley. These collaborations foster a stimulating research environment that enhances the potential for groundbreaking discoveries.

Conclusion

Srinivas Paladugu's work stands as a testament to the power of innovation in healthcare. Through his research and patent contributions, he plays a crucial role in the quest for effective treatments, embodying the spirit of invention that drives progress in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…